PGNX - Progenics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts4144
Avg. Estimate-0.23-0.19-0.92-0.62
Low Estimate-0.26-0.19-0.95-0.73
High Estimate-0.21-0.19-0.9-0.47
Year Ago EPS-0.1-0.230.15-0.92
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts4144
Avg. Estimate3.2M4.7M11.03M41.52M
Low Estimate3M4.7M10.8M32.1M
High Estimate3.6M4.7M11.4M48.9M
Year Ago Sales4.65M2.35M69.43M11.03M
Sales Growth (year/est)-31.20%100.30%-84.10%276.40%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.2-0.19-0.21-0.23
EPS Actual-0.1-0.23-0.24-0.22
Difference0.1-0.04-0.030.01
Surprise %50.00%-21.10%-14.30%4.30%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.23-0.19-0.92-0.62
7 Days Ago-0.23-0.19-0.92-0.62
30 Days Ago-0.23-0.19-0.92-0.62
60 Days Ago-0.23-0.13-0.92-0.4
90 Days Ago-0.2-0.13-0.9-0.36
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesPGNXIndustrySectorS&P 500
Current Qtr.-130.00%N/AN/A0.26
Next Qtr.17.40%N/AN/A0.34
Current Year-713.30%N/AN/A0.09
Next Year32.60%N/AN/A0.15
Next 5 Years (per annum)296.40%N/AN/A0.11
Past 5 Years (per annum)-16.22%N/AN/AN/A